- Novo Nordisk ousts CEO after falling behind in weight loss market Reuters
- Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs The New York Times
- Ozempic CEO’s Exit From Novo Started With Teams Call Surprise Bloomberg
- Novo Nordisk Boots CEO Lars Jørgensen After Stock Falls. It’s Out of Character for Wegovy Drugmaker. Barron’s
- Wegovy-maker Novo Nordisk abruptly ousts chief executive BBC